Table 4.
Global results on PTVs from dose plan analysis. For each TPS the averages over all the patients and target volumes are shown, uncertainties are reported at 1 standard deviation. D1% and D99% are reported as percentage of the prescribed dose.
| Objective | Corvus1 | Eclipse1 | Hyperion2 | KonRad1 | OMP2 | PinnEUD2 | PinnPhy2 | Precise2 | |
| D1% % | 100 | 112 ± 2 | 107 ± 4 | 109 ± 4 | 113 ± 6 | 111 ± 5 | 126 ± 24 | 116 ± 13 | 114 ± 7 |
| D99% % | 100 | 81 ± 6 | 87 ± 5 | 82 ± 9 | 78 ± 10 | 87 ± 4 | 68 ± 31 | 77 ± 22 | 83 ± 7 |
| V90% % | 100% | 93.8 ± 3.7 | 97.1 ± 2.6 | 95.2 ± 2.9 | 96.6 ± 2.0 | 97.8 ± 1.2 | 83.8 ± 18.5 | 88.4 ± 12.6 | 95.6 ± 3.3 |
| V107% % | 0% | 13.3 ± 6.5 | 3.9 ± 5.6 | 5.9 ± 4.8 | 9.6 ± 5.7 | 4.6 ± 3.5 | 24.1 ± 21.7 | 18.7 ± 20.9 | 10.2 ± 6.9 |
| SD Gy | 0 Gy | 1.63 ± 1.39 | 1.19 ± 1.15 | 1.37 ± 1.08 | 1.44 ± 1.12 | 1.14 ± 1.02 | 1.87 ± 0.88 | 1.26 ± 0.66 | 1.54 ± 1.36 |
| CI | 1.00 | 1.29 ± 0.29 | 1.16 ± 0.09 | 1.34 ± 0.24 | 1.26 ± 0.14 | 1.35 ± 0.16 | 1.28 ± 0.30 | 1.32 ± 0.30 | 1.31 ± 0.14 |
1: TPS belonging to the first family type
2: TPS belonging to the second family type